2021年最新SCI期刊影响因子查询系统
Expert Review of Respiratory Medicine 期刊详细信息
基本信息
期刊名称 | Expert Review of Respiratory Medicine Expert Review of Respiratory Medicine |
---|---|
期刊ISSN | 1747-6348 |
期刊官方网站 | http://www.tandfonline.com/loi/ierx20 |
是否OA | 否 |
出版商 | Taylor and Francis Ltd. |
出版周期 | |
始发年份 | |
年文章数 | 86 |
最新影响因子 | 4.3(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | RESPIRATORY SYSTEM 呼吸系统4区 | 否 | 是 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 2.18 | 0.861 | 0.657 |
Medicine Pulmonary and Respiratory Medicine |
48 / 134 | 64% |
|||
Medicine Immunology and Allergy |
99 / 188 | 47% |
|||
Medicine Public Health, Environmental and Occupational Health |
119 / 489 | 75% |
补充信息
自引率 | 2.80% |
---|---|
H-index | 28 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1747-6348%5BISSN%5D |
投稿指南
期刊投稿网址 | https://mc.manuscriptcentral.com/errx |
---|---|
收稿范围 | Respiratory disease imposes a global burden affecting hundreds of millions of people. More than 380 million people worldwide suffer from chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The World Health Organization (WHO) estimates that 4 million deaths in 2005 were caused by chronic respiratory diseases, and these numbers are set to increase by an estimated 30% over the coming decade. Currently, pneumonia and COPD are two of the four leading causes of death worldwide, together with HIV/AIDS and cardiovascular disease. Among those with HIV/AIDS, tuberculosis accounts for a quarter of a million deaths each year. Furthermore, a recent WHO survey reported that nearly a quarter of all deaths and of the total disease burden across the world can be attributed to environmental risk factors. Again, respiratory diseases such as COPD and lower respiratory infections were among the principal causes of death. Despite the fact that smoking is known to be the primary risk factor for many pulmonary diseases, statistics show that the tobacco epidemic is growing in the developing world and remains high in the West. Given the intractable nature of the established diseases and emerging threats, such as the rise in allergies and a potential global avian influenza pandemic, the importance of respiratory medicine has never been greater. The challenge for clinicians, researchers and others involved in respiratory medicine is to stay abreast of the latest developments in the field. Expert Review of Respiratory Medicine (ISSN 1747-6348) provides an authoritative and focused solution, delivering commentary and analysis for those involved in all areas of pulmonary medicine. Coverage will include the following key areas: • Prospects for new and emerging therapeutics • Epidemiology of disease • Preventive strategies • All aspects of COPD, from patient self-management to systemic effects of the disease and comorbidities • Improved diagnostic methods, including imaging techniques, biomarkers and physiological tests. • Advances in the treatment of respiratory infections and drug resistance issues • Occupational and environmental factors • Progress in smoking intervention and cessation methods • Disease and treatment issues for defined populations, such as children and the elderly • Respiratory intensive and critical care • Updates on the status and advances of specific disease areas, including asthma, HIV/AIDS-related disease, cystic fibrosis, COPD and sleep-disordered breathing morbidity Expert Review of Respiratory Medicine provides evaluated and structured commentary from international leaders in the fields of obstructive, restrictive, vascular and infectious respiratory diseases. All reviews are subject to peer review and produced to industry leading standards and timelines to ensure a complete solution for professionals working in the field. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |